6th International China Pharmaceutical R&D Summit

Venue: Grang Hyatt

Location: Shanghai, China

Event Date/Time: Apr 11, 2011 End Date/Time: Apr 13, 2011
Report as Spam

Description

A never-before line-up of over 80 Speakers from international pharma, MNCs in China, and domestic Chinese pharma/biotechs
will be sharing their expert opinions and experiences on transformation & innovation in China, clinical challenges, regulatory
updates , NCE discovery efforts, preclinical partnerships, biosimilars development and more!

The 2011 event will feature 3 concurrent conferences – Clinical & Regulatory Summit; Discovery to PreClinical Development & Partnerships; and Biologics & Biosimilars Development, with shared Keynotes and a Plenary Session focusing on Transformation & Innovation in China-the Next Stage in China’s Life Sciences Industry. Participants will be able to choose the conference of their choice or mix-and-match sessions from all 3 conferences, while taking advantage of the shared sessions and networking breaks to meet with other executives and scientists at the event.

With proven attendance from top-level executives from China’s major pharma and
biotech companies, this is THE MEETING PLACE to network and share experiences,
meet potential partners and foster business relationships.

Clinical & Regulatory Summit:
Understand the Regulatory Environment in China
• Hear from a tuned-in clinical CRO on the changing Chinese regulatory system; a US company’s insight on conducting global trials in Asia’s dynamic regulatory environment; and a leading consultant’s strategy to bring
Chinese-originated drugs and biologics to US market.
• Benefit from these Tried & Proven Clinical Strategies and Case Studies:
• FIH Study in China: from IND Application to Study Completion
• Getting Ready for Global Trials in China
• Conducting Health Economics & Outcomes Research in China
• Developing Risk Management Plan in Clinical Trials
• Bridging China Data with Global Data – Global Simultaneous Development
• Trials & Tribulations of Starting Clinical Trials in a New Geographic Region

Discovery to Preclinical Development & Partnerships:
*Hear the Latest in NCE Development from these Domestic Chinese Companies:
• Dongyangguang Pharmaceuticals, Ascentage Pharma, IMPACT Therapeutics, Sunwei Therapeutics, Argusina Shanghai, Nanjing Changao Pharmaceutical, Luye Pharma Group and TOT Shanghai
*Get Exciting Partnering Strategies and Updates from:
• Roche, Simcere Pharmaceuticals, Pfizer, AstraZeneca, Fosun Pharmaceutical ,
Synta Pharmaceuticals, DCB Taiwan, GSK and Eli Lilly

Venue